---
schema_version: "secwatch.filing_event.v1"
accession: "0001005286-26-000023"
form_type: "8-K"
ticker: "LFCR"
cik: "0001005286"
company_name: "LIFECORE BIOMEDICAL, INC. DE"
filed_at: "2026-06-05T20:10:37+00:00"
generated_at: "2026-06-05T20:21:58.700828+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Lifecore stockholders approve 2026 equity plan; all director nominees elected at annual meeting

## Summary
- Stockholders approved 2026 Stock Incentive Plan (2.5M new shares plus forfeited 2019 Plan shares) effective Oct 16, 2026.
- All nine director nominees elected: 7 by all stockholders (Houde, Antunes, Johnson, Josephs, Korenberg, Obus, Schechter); 2 by Series A preferred (Aryeh, Kiper).
- Ratified KPMG as auditor (33.8M for); approved non-binding say-on-pay (22.9M for).

## SEC filing metadata
- accession: 0001005286-26-000023
- form_type: 8-K
- ticker: LFCR
- cik: 0001005286
- company_name: LIFECORE BIOMEDICAL, INC. DE
- filed_at: 2026-06-05T20:10:37+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1005286/000100528626000023/0001005286-26-000023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1005286/000100528626000023/lfcr-20260604.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001005286-26-000023
- JSON: https://secwatch.observer/filing/0001005286-26-000023.json
- Plain text: https://secwatch.observer/filing/0001005286-26-000023.txt

## Key facts
- Shareholder Votes
  LIFECORE BIOMEDICAL, INC. DE shareholders approved Non-binding advisory proposal approving the compensation of the Company's named executive officers. at the 2026-06-04 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-04
  source text: 3. Stockholders approved the compensation paid to the Company's named executive officers (in the form of a non-binding, advisory vote), with votes as follows: Votes For Votes Against Abstain Broker Non-Votes 22,938,684 178,868 12,851 10,697,326
  evidence_url: https://www.sec.gov/Archives/edgar/data/1005286/000100528626000023/0001005286-26-000023-index.htm
- Shareholder Votes
  LIFECORE BIOMEDICAL, INC. DE shareholders approved To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. at the 2026-06-04 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-04
  source text: 2. Stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026, with votes as follows: Votes For Votes Against Abstain 33,760,879 63,445 3,405
  evidence_url: https://www.sec.gov/Archives/edgar/data/1005286/000100528626000023/0001005286-26-000023-index.htm
- Shareholder Votes
  LIFECORE BIOMEDICAL, INC. DE shareholders approved To approve the Lifecore Biomedical, Inc. 2026 Stock Incentive Plan. at the 2026-06-04 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2026-06-04
  source text: 4.Stockholders approved the Lifecore Biomedical, Inc. 2026 Stock Incentive Plan, with votes as follows: Votes For Votes Against Abstain Broker Non-Votes 22,724,492 392,825 13,086 10,697,326
  evidence_url: https://www.sec.gov/Archives/edgar/data/1005286/000100528626000023/0001005286-26-000023-index.htm
- Shareholder Votes
  LIFECORE BIOMEDICAL, INC. DE shareholders approved Election of nine directors at the 2026-06-04 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-04
  source text: 1. Stockholders elected the nine director nominees and the voting results were as follows: Directors Elected by All Stockholders Votes For Votes Against Votes Withheld Broker Non-Votes Katrina L. Houde 19,790,359 3,336,694 3,350 10,697,326 Humberto C. Antunes 21,713,661 1,408,873 7,869 10,697,326 Paul H. Johnson 21,920,254 1,206,182 3,967 10,697,326 Paul Josephs 23,068,707 57,729 3,967 10,697,326 Matthew E. Korenberg 21,432,586 1,693,825 3,992 10,697,326 Nelson Obus 21,450,647 1,675,206 4,550 10,697,326 Joshua E. Schechter 20,394,278 2,731,575 4,550 10,697,326 Directors Elected by the Series A Preferred Stockholders Votes For Votes Against Votes Withheld Broker Non-Votes Jason Aryeh 28,287 — — — Christopher S. Kiper 28,287 — — —
  evidence_url: https://www.sec.gov/Archives/edgar/data/1005286/000100528626000023/0001005286-26-000023-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.